
    
      Open, one arm, single sequence study for healthy volunteers are investigated. Thirty four
      subjects may be enrolled.

      Rosuvastatin are administered once a day for 21 days. Before and after rosuvastatin
      administration, PK, PD and lipid profiles are investigated.
    
  